US health officials nix publication of a study on COVID vaccine effectiveness

U.S. health officials have stopped the publication of a study on the COVID-19 vaccine's effectiveness in preventing ...
Forbes

Long COVID — Here’s What To Know And The Challenges Ahead

Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. This voice experience is generated by AI. Learn more. This voice ...
News Medical

WHO’s new pandemic measures may ignore lessons from COVID-19

Researchers at the University of Leeds, UK, have recently analyzed the World Health Organization (WHO) 's pre- and post-pandemic reports to explore the scientific basis and rationale for ...

New Information Regarding the Relationship Between COVID-19 and Breast Cancer Recurrence

A recent study examines the association between COVID-19 infection and an increased risk of recurrence in breast cancer ...
MPR

Protein-Based COVID-19 Vaccine Demonstrates Superior Tolerability to mRNA Comparator

Phase 4 COMPARE trial data show Nuvaxovid was associated with lower reactogenicity and fewer daily activity disruptions than mNEXSPIKE.
News Medical

COVID-19 ARDS survivors face lasting disability and high late mortality, researchers report

Four years after ICU admission, mortality remains strikingly high in ventilated COVID-19 ARDS patients, and many survivors continue to struggle with fatigue, insomnia, functional decline, and ...

Elon Musk Questions COVID-19 Vaccine Dosage, Says It Was 'Obviously Too High'

Tesla Inc. CEO Elon Musk expressed his concerns over the COVID-19 vaccine dosage, citing his own adverse experience. Musk ...